Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Detection of Solid Tumor Molecular Residual DiseaseĀ (MRD) Using Circulating Tumor DNA (ctDNA).

Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, Azad TD, Dudley JC, Chaudhuri AA.

Mol Diagn Ther. 2019 Jun;23(3):311-331. doi: 10.1007/s40291-019-00390-5. Review.

2.

Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.

Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova YM, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):522-529. doi: 10.1016/j.ijrobp.2019.03.004. Epub 2019 Mar 8.

PMID:
30858143
3.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG.

Blood. 2019 Jan 17;133(3):237-245. doi: 10.1182/blood-2018-04-843540. Epub 2018 Nov 16.

PMID:
30446493
4.

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, Brown JM, Maxim PG, Koong AC, Graves EE, Loo BW Jr.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1183-1192. doi: 10.1016/j.ijrobp.2018.03.045. Epub 2018 Apr 18.

PMID:
29859786
5.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.

6.

Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.

Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW Jr.

Radiother Oncol. 2017 May;123(2):270-275. doi: 10.1016/j.radonc.2017.03.021. Epub 2017 Apr 28.

PMID:
28460826
7.

Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).

Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, Le QT, Diehn M, Loo BW Jr, Guo HH.

Radiother Oncol. 2016 Jun;119(3):454-60. doi: 10.1016/j.radonc.2016.05.007. Epub 2016 Jun 3.

PMID:
27267049
8.

Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab.

Chaudhuri AA, Chen JJ, Carter JN, Binkley MS, Kumar KA, Dudley SA, Sung AW, Loo BW Jr.

Cureus. 2016 Apr 19;8(4):e578. doi: 10.7759/cureus.578.

9.

Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative Radiotherapy.

Chaudhuri AA, Binkley MS, Aggarwal S, Qian Y, Carter JN, Shah R, Loo BW Jr.

Cureus. 2016 Feb 2;8(2):e477. doi: 10.7759/cureus.477.

10.

Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.

Hiniker SM, Modlin LA, Choi CY, Atalar B, Seiger K, Binkley MS, Harris JP, Liao YJ, Fischbein N, Wang L, Ho A, Lo A, Chang SD, Harsh GR, Gibbs IC, Hancock SL, Li G, Adler JR, Soltys SG.

Semin Radiat Oncol. 2016 Apr;26(2):97-104. doi: 10.1016/j.semradonc.2015.11.008. Epub 2015 Dec 4. Review.

PMID:
27000505
11.

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.

Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW Jr.

Radiat Oncol. 2016 Mar 15;11:40. doi: 10.1186/s13014-016-0616-8.

12.

Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma.

Binkley MS, Hiniker SM, Donaldson SS, Hoppe RT.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):255-61. doi: 10.1016/j.prro.2015.11.013. Epub 2015 Nov 22.

PMID:
26935235
13.

Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.

Binkley MS, Hiniker SM, Chaudhuri A, Maxim PG, Diehn M, Loo BW Jr, Shultz DB.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):808-15. doi: 10.1016/j.ijrobp.2015.12.007. Epub 2015 Dec 17.

PMID:
26831903
14.

Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M.

Semin Radiat Oncol. 2015 Oct;25(4):305-12. doi: 10.1016/j.semradonc.2015.05.001. Epub 2015 May 15. Review.

15.

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.

Binkley MS, Hiniker SM, Wu S, Natkunam Y, Mittra ES, Advani RH, Hoppe RT.

Leuk Lymphoma. 2016;57(3):604-8. doi: 10.3109/10428194.2015.1067700. Epub 2015 Aug 28.

PMID:
26159046
16.

Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy.

Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW Jr, Shultz DB, Diehn M.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1044-1052. doi: 10.1016/j.ijrobp.2015.04.004. Epub 2015 Apr 8.

PMID:
26025776
17.

Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.

Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW Jr, Diehn M.

Lung Cancer. 2015 Jul;89(1):50-6. doi: 10.1016/j.lungcan.2015.04.014. Epub 2015 May 4.

PMID:
25997421
18.

Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.

Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW Jr.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):216-23. doi: 10.1016/j.ijrobp.2014.05.025. Epub 2014 Jul 8.

PMID:
25015205
19.

Highly selective alpha-acylvinyl anion additions to imines.

Reynolds TE, Binkley MS, Scheidt KA.

Org Lett. 2008 Nov 20;10(22):5227-30. doi: 10.1021/ol802227t. Epub 2008 Oct 30.

PMID:
18959427
20.

Lewis acid-catalyzed conjugate additions of silyloxyallenes: a selective solution to the intermolecular Rauhut-Currier problem.

Reynolds TE, Binkley MS, Scheidt KA.

Org Lett. 2008 Jun 19;10(12):2449-52. doi: 10.1021/ol800745q. Epub 2008 May 14.

Supplemental Content

Loading ...
Support Center